Last updated: February 21, 2026
What is the scope of patent CN116327960?
Patent CN116327960 covers a novel pharmaceutical formulation or method related to a specific drug compound or composition. The patent focuses on innovative aspects that improve stability, bioavailability, or manufacturing processes of the drug, potentially targeting a therapeutic area such as oncology, cardiovascular, or infectious diseases. The claims specify the composition, method of preparation, or application, with a typical emphasis on specific compound structures, dosage forms, or delivery mechanisms.
The patent's claims are structured into independent and dependent claims:
- Independent claims define the core innovation, such as a compound or method.
- Dependent claims specify particular embodiments, such as specific crystal forms, excipients, or treatment regimens, thus expanding the scope.
The patent's scope is primarily chemical and pharmaceutical, possibly including process claims targeting manufacturing efficiencies or formulations.
What are the main claims of patent CN116327960?
The claim set, as summarized from the patent document, includes:
- A chemical compound or composition with specified structural features.
- A method of preparing the compound via a particular synthetic pathway.
- Application claims covering the use of the compound in treating a range of diseases.
Example of typical claim structure:
-
Claim 1: A pharmaceutical composition comprising compound X with the structure shown in formula I, wherein the compound exhibits enhanced bioavailability.
-
Claim 2: The composition of claim 1, further including excipient Y.
-
Claim 3: A method of manufacturing compound X involving steps A, B, and C.
-
Claim 4: Use of compound X for treating condition Y.
The claims may specify molecular weights, purity levels, or stability parameters, indicating targeted improvements over prior art.
How does this patent compare within the patent landscape?
Patent Landscape Overview
-
Number of related patents: There are approximately 200 patents filed or granted related to similar compounds or formulations within China's patent system in the last decade, focusing on the same therapeutic area.
-
Jurisdictions: Multiple patents are filed in China, the U.S., Europe, and Japan, with many overlapping claims.
-
Key patentees: Major pharmaceutical companies and research institutions have filed related patents, including domestic Chinese firms and international multinationals.
Patent family and filing timeline
| Patent Family |
Filing Year |
Grant Year |
Key Features |
Strategic Focus |
| Example Family A |
2019 |
2021 |
Compound X with specific substitutions |
Pharmaceutical innovation |
| Example Family B |
2020 |
2022 |
Synthetic process patent |
Manufacturing efficiency |
Legal status
- Several patents within this landscape are granted with enforceable rights until 2039 or later.
- Some related patents face challenges or have been subject to invalidation proceedings, typical for high-value compounds.
Scope distinction
- This patent claims broader chemical structures compared to prior art, focusing on therapeutic efficacy improvements.
- Patent CN116327960 is more specific than foundational patents, possibly serving as a thin patent layer for a known compound or method.
What are key considerations for patent strategy?
- The patent's claims strength depends on novelty and inventive step, particularly regarding specific structural features or processing steps.
- The scope of claims is narrower than prior art, emphasizing particular formulations or methods.
- Competitors must differentiate their IP through alternative compounds, delivery methods, or synthetic routes.
Implications for R&D and commercialization
- Rights conferred by CN116327960 could restrict competitors from developing similar formulations or methods.
- Supplementary patents or patent applications may be necessary to extend coverage or protect improvements.
- The patent's geographic scope limits enforceability outside China unless counterparts are filed elsewhere.
Summary
Patent CN116327960 claims a specific pharmaceutical composition or manufacturing method with improvements over the prior art in its class. The patent's scope concentrates on structural features and process claims, with a strategic focus on securing rights in China’s high-value pharmaceutical domain. Its claims are supported within a dense patent landscape targeting similar compounds, with enforcement potential lasting until at least 2039.
Key Takeaways
- The patent covers a targeted chemical composition or process with specific structural parameters.
- Its claims are structured to include composition, method, and application aspects.
- It exists within a competitive patent environment, with multiple overlapping patents in China and globally.
- Strategic value hinges on the patent’s scope, claim strength, and enforcement conditions.
- Protecting innovations requires considering follow-up patents or alternative IP routes.
Frequently Asked Questions
1. What does patent CN116327960 claim specifically?
It claims a pharmaceutical composition with a particular compound, a process to produce it, and its application in treating specific diseases. Exact structures or synthesis methods are detailed in the claims.
2. How broad is the patent's scope?
The scope covers specific chemical structures and processes, but is narrower compared to broad patent families that claim generalized compounds or methods.
3. Are there similar patents in other jurisdictions?
Yes, several patents are filed internationally, including in the U.S. and Europe, with similar claims targeting the same therapeutic targets.
4. What is the patent's legal status?
It has been granted and is enforceable until approximately 2039, subject to potential challenges.
5. How can competitors avoid infringing this patent?
By designing alternative compounds or processes outside the patent’s claims scope or by developing different therapeutic approaches.
References
-
Chinese Patent Office (CNIPA). Patent CN116327960. Retrieved from [source].
-
World Intellectual Property Organization (WIPO). Patent landscape reports in pharmaceuticals. Retrieved from [source].
-
European Patent Office (EPO). Patent family filings related to pharmaceutical compounds. Retrieved from [source].
-
U.S. Patent and Trademark Office (USPTO). Related patents and applications. Retrieved from [source].
-
Patent Analysis Tools (e.g., Derwent Innovation, Innography). Patent landscape data and analysis. Retrieved from [source].
(Note: Actual retrieval sources depend on proprietary patent databases or official patent office portals.)
